The role of Astragalus membranaceus and its derivatives in digestive system diseases: reconstruction of immune tolerance - Scorecard - MDSpire

The role of Astragalus membranaceus and its derivatives in digestive system diseases: reconstruction of immune tolerance

  • By

  • Xinyue Chang

  • Xin Zhang

  • Hanqing Guo

  • Xinqi Yao

  • Jun Zhang

  • Kun Zhuang

  • Lin Li

  • June 17, 2026

  • 0 min

Share

Clinical Scorecard: The Impact of Astragalus membranaceus and Its Derivatives on Immune Tolerance in Gastrointestinal Disorders

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with digestive diseases experiencing immune dysregulation.
Care Setting

Key Highlights

    Guideline-Based Recommendations

    Diagnosis

      Management

        Monitoring & Follow-up

          Risks

            Patient & Prescribing Data

            Patients with digestive diseases experiencing immune dysregulation.

            AM and its derivatives may offer a novel approach to managing immune tolerance.

            Clinical Best Practices

              Related Resources & Content

              Original Source(s)

              The role of Astragalus membranaceus and its derivatives in digestive system diseases: reconstruction of immune tolerance

              • by Xinyue Chang, Xin Zhang, Hanqing Guo, Xinqi Yao, Jun Zhang, Kun Zhuang, Lin Li

              • June 17, 2026

              Related Content

              Safety evaluation of subcutaneous and intravenous administration of infliximab: a real-world study based on the FAERS database

              Deep learning-based quantitative histopathology of endoscopic biopsies in Crohn’s disease: a retrospective cross-sectional validation study

              Commentary: SEMA3B is associated with disease activity and infliximab response in IBD patients but does not contribute to the development of intestinal inflammation in vivo